CAS 956958-53-5 appears in our catalog under these names: XL147, Pilaralisib analogue/ 99.46% (existing batch purity), Pilaralisib analogue, 99.74%, Pilaralisib analogue, 98%. Offered by: GLPBio, TargetMol, Chemat, MedChemExpress, Fluorochem. Available pack sizes: 5mg, 10mg, 25mg, 50mg, 100mg, 200mg, 10mM (in 1ml dmso), 1mg.
XL147 is a sulfonamide that is the N-4-toluenesulfonyl (N-tosyl) derivative of N-(2,1,3-benzothiadiazol-5-yl)quinoxaline-2,3-diamine. A selective PI3K inhibitor used in cancer treatment. It has a role as an antineoplastic agent and an EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor. It is an aromatic amine, a sulfonamide, a quinoxaline derivative and a benzothiadiazole.
Source: ChEBI
| Molecular formula | C21H16N6O2S2 |
|---|---|
| Molecular weight | 448.5 g/mol |
| IUPAC name | N-[3-(2,1,3-benzothiadiazol-5-ylamino)quinoxalin-2-yl]-4-methylbenzenesulfonamide |
| InChIKey | MQMKRQLTIWPEDM-UHFFFAOYSA-N |
| SMILES | CC1=CC=C(C=C1)S(=O)(=O)NC2=NC3=CC=CC=C3N=C2NC4=CC5=NSN=C5C=C4 |
Computed by PubChem (NCBI)